Literature DB >> 17400680

Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease.

Won-Jung Koh1, Jun Haeng Lee, Yong Soo Kwon, Kyung Soo Lee, Gee Young Suh, Man Pyo Chung, Hojoong Kim, O Jung Kwon.   

Abstract

BACKGROUND: Knowledge of the relationship between respiratory disorders and gastroesophageal reflux disease (GERD) is increasing. However, the association between GERD and pulmonary disease caused by nontuberculous mycobacteria (NTM) has not been studied in detail. We investigated the prevalence of GERD in patients with the nodular bronchiectatic form of NTM lung disease.
METHODS: Fifty-eight patients with the nodular bronchiectatic form of NTM lung disease underwent ambulatory 24-h esophageal pH monitoring. Of the 58 patients, 27 patients were identified as having Mycobacterium avium complex infection (15 with Mycobacterium intracellulare and 12 with M avium), and 31 patients had Mycobacterium abscessus pulmonary infection.
RESULTS: The prevalence of GERD in patients with the nodular bronchiectatic form of NTM lung disease was 26% (15 of 58 patients). Only 27% (4 of 15 patients) had typical GERD symptoms. No statistically significant differences were found between patients with GERD and those without GERD with regard to age, sex, body mass index, or pulmonary function test results. However, patients with GERD were more likely to have a sputum smear that was positive for acid-fast bacilli (12 of 15 patients, 80%), compared with patients without GERD (19 of 43 patients, 44%) [p = 0.033]. In addition, bronchiectasis and bronchiolitis were observed in more lobes in patients with GERD than in patients without GERD (p = 0.008 and p = 0.005, respectively).
CONCLUSIONS: Patients with the nodular bronchiectatic form of NTM lung disease have a high prevalence of increased esophageal acid exposure, usually without typical GERD symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17400680     DOI: 10.1378/chest.06-2280

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

Review 2.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 4.  Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.

Authors:  Leopoldo N Segal; William N Rom; Michael D Weiden
Journal:  Ann Am Thorac Soc       Date:  2014-01

5.  Can physics principles help explain why non-tuberculous mycobacterial lung disease is more severe in the right middle lobe and lingula?

Authors:  Sangbong Choi; John C Richards; Edward D Chan
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

6.  Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.

Authors:  Timothy R Aksamit; Anne E O'Donnell; Alan Barker; Kenneth N Olivier; Kevin L Winthrop; M Leigh Anne Daniels; Margaret Johnson; Edward Eden; David Griffith; Michael Knowles; Mark Metersky; Matthias Salathe; Byron Thomashow; Gregory Tino; Gerard Turino; Betsy Carretta; Charles L Daley
Journal:  Chest       Date:  2016-11-23       Impact factor: 9.410

7.  Nontuberculous mycobacterial lung infections in patients with eating disorders: plausible mechanistic links in a case series.

Authors:  Daniela E Grayeb; Edward D Chan; Leah M Swanson; Dennis G Gibson; Philip S Mehler
Journal:  AME Case Rep       Date:  2021-01-25

Review 8.  Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Microbiol Spectr       Date:  2017-06

9.  Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.

Authors:  Leopoldo N Segal; Jose C Clemente; Jun-Chieh J Tsay; Sergei B Koralov; Brian C Keller; Benjamin G Wu; Yonghua Li; Nan Shen; Elodie Ghedin; Alison Morris; Phillip Diaz; Laurence Huang; William R Wikoff; Carles Ubeda; Alejandro Artacho; William N Rom; Daniel H Sterman; Ronald G Collman; Martin J Blaser; Michael D Weiden
Journal:  Nat Microbiol       Date:  2016-04-04       Impact factor: 17.745

10.  Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.

Authors:  Catherine H Miele; Kristin Schwab; Rajeev Saggar; Erin Duffy; David Elashoff; Chi-Hong Tseng; Sam Weigt; Deepshikha Charan; Fereidoun Abtin; Jimmy Johannes; Ariss Derhovanessian; Jeffrey Conklin; Kevin Ghassemi; Dinesh Khanna; Osama Siddiqui; Abbas Ardehali; Curtis Hunter; Murray Kwon; Reshma Biniwale; Michelle Lo; Elizabeth Volkmann; David Torres Barba; John A Belperio; David Sayah; Thomas Mahrer; Daniel E Furst; Suzanne Kafaja; Philip Clements; Michael Shino; Aric Gregson; Bernard Kubak; Joseph P Lynch; David Ross; Rajan Saggar
Journal:  Ann Am Thorac Soc       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.